The tariff classification of Liothyronine Sodium Tablets in dosage form, from India
Reasoning
The tariff classification of Liothyronine Sodium Tablets in dosage form, from India
Cite this ruling
CBP Ruling N314838 (3004390050): The tariff classification of Liothyronine Sodium Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300439
The tariff classification and country of origin marking of LUPRON DEPOT 7.5 mg (leuprolide acetate for depot suspension) prefilled dual-chamber syringe; and the tariff classification of plastic plungers for syringes from Japan
The tariff classification of recombinant human interferonbeta, in bulk form and put up in measured doses, from the UnitedKingdom
Application For Further Review of Protest No.3801-2-101743; Locoid and Hydrocortisone Butyrate
In your letter of June 16, 1993, you requested aclassification ruling for merchandise known as Budesonide, ananti-inflammatory drug imported in bulk form and imported infinished products as inhalers in saleable units. You received aresponse for the classification of the merchandise imported inbulk form by New York Ruling Letter 887496, dated July 19, 1993,which classified the bulk product under subheading 2937.29.0050,Harmonized Tariff Schedule of the United States (HTSUS), dutiableat 6 percent ad valorem. The following is our decisionconcerning the classification for the inhalers containingBudesonide and imported for retail trade.
Sometribove-zinc complex bovine somatotropin (BST); Posilac; bovine growth hormone; hormones; medicaments; 2937